Psychedelic stocks: Don't bet on just 1 company

13 lug 2023 · 36 min. 52 sec.

Descrizione

Will tough times continue for psychedelic stocks? (1:50) Analyst https://seekingalpha.com/author/ALEXANDER-CARCHIDI?source=ie_podcast:psychedelic_stocks_dont_bet_on_just_one shares his views on the sector and specific stocks like https://seekingalpha.com/symbol/CMPS?source=ie_podcast:psychedelic_stocks_dont_bet_on_just_one (4:20), https://seekingalpha.com/symbol/ATAI?source=ie_podcast:psychedelic_stocks_dont_bet_on_just_one and https://seekingalpha.com/symbol/CYBN?source=ie_podcast:psychedelic_stocks_dont_bet_on_just_one (19:50) and the inevitability of...

mostra di più

Will tough times continue for psychedelic stocks? (1:50) Analyst Alex Carchidi shares his views on the sector and specific stocks like Compass Pathways (4:20), Atai and Cybin (19:50) and the inevitability of big pharma buying up assets (32:10).

Transcripts available on Seeking Alpha

Cybin: A Leading Early-Stage Psychedelics Play
American Medical Association approves CPT code for psychedelic therapies
FDA drafts new guidance on psychedelic research
Psychedelic Sunday: Scrutinizing Psychedelic Stocks

mostra meno

Commenti

Accedi per lasciare un commento

Informazioni

Autore	Seeking Alpha
Organizzazione	Seeking Alpha
Sito	seekingalpha.com
Tag	#atai #biotech #clinical #comp360 #compass #cybin #healthcare #ketamine #mdma #mentalhealth #pharma #psilocybin #psychedelics #ptsd #stocks #therapy #trials